MAPT and Alzheimer disease: Currently, it is widely accepted that the classic AD hallmarks, Aβ aggregates and hyperphosphorilated Tau intracellular deposits, are insufficient to explain AD onset and progression, and the amyloid-inflammatory cascade has been recently formulated [3,4].